Pediatric precursor B-cell acute lymphoblastic leukemia with MYC 8q24 translocation

Pediatric precursor B-cell acute lymphoblastic leukemia with MYC 8q24 translocation – how to treat?

Published:2017-10-12 Issue:8 Volume:59 Page:1807-1813
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Zhang Chuer¹,Amos Burke Gladstone Austin²

Affiliation:

1. School of Clinical Medicine, University of Cambridge, Cambridge, UK;

2. Department of Paediatric Haematology, Oncology and Palliative Care, Addenbrooke’s Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2017.1387914

Reference24 articles.

1. A 50-Year Journey to Cure Childhood Acute Lymphoblastic Leukemia

2. Results of the randomized Intergroup trial Inter-B-NHL Ritux 2010 for children and adolescents with high-risk B-cell non-Hodgkin lymphoma (B-NHL) and mature acute leukemia (B-AL): Evaluation of rituximab (R) efficacy in addition to standard LMB chemotherapy (CT) regimen.

3. DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA

4. Burkitt's Lymphoma: Clinicopathologic Features and Differential Diagnosis

5. Prognostic implications of chromosomal findings in acute lymphoblastic leukaemia at diagnosis.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Guillain–Barre syndrome as a paraneoplastic phenomenon in a child with MYC rearranged B‐cell acute lymphoblastic leukemia;Pediatric Blood & Cancer;2024-01-30

2. Causes of death and treatment-related mortality in newly diagnosed childhood acute lymphoblastic leukemia treatment with Chinese Children’s Cancer Group study ALL-2015;Annals of Hematology;2023-08-08

3. Molecular characterization and clinical outcome of B-cell precursor acute lymphoblastic leukemia with IG-MYC rearrangement;Haematologica;2022-04-28

4. Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic Leukemia;Frontiers in Oncology;2021-12-01

5. References;Flow Cytometry of Hematological Malignancies;2021-04-06